group pushes for stem cell testing astrazeneca plc glaxosmithkline plc and roche holding ag have teamed with the british government to push forward the development of stem cell technology to be used to test new drugs for harmful side effects before they enter human trials astrazenecas director of molecular toxicology ian cotgreave said new techniques will enable drug companies to test experimental products on human tissue before entering expensive late stage trials where it isnt uncommon to discover side effects the three drug giants have each committed an initial gbp &# for setting up an independent not for profit company called stem cells for safer medicines ltd to provide guidance and funding for stem cell research in the u k 
